Clinical Trials · NCT03562130
Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 25
- Start date
- Jul 2018
- Locations
- 1 site, France
- Primary endpoint
- Decrease in parenteral nutrition: Parenteral Nutrition/Resting Energy Expenditure (PN/REE)